During his time as CEO, Larry J. Merlo's wealth was closely tied to his holdings in CVS Health, particularly surrounding major corporate events. Notably, Merlo had large equity stakes, which reflected the company's growth trajectory and stock performance. In 2013...

During his time as CEO, Larry J. Merlo's wealth was closely tied to his holdings in CVS Health, particularly surrounding major corporate events. Notably, Merlo had large equity stakes, which reflected the company's growth trajectory and stock performance. In 2013 and 2014, he amassed significant wealth through stock options and bonuses, reaching total compensations exceeding $30 million. However, his net worth fluctuated based on market conditions and company performance metrics. By the end of his tenure in 2021, he had a diverse portfolio of vested stock awards, underscoring his commitment to CVS. Throughout his tenure, he maintained a considerable number of vested and unvested shares, enabling him to benefit from CVS's market performance, while the value of his holdings reflected broader trends in the healthcare landscape and CVS's pivotal acquisitions. His retirement saw a well-structured payout and benefits package, emphasizing his influence in shaping CVS into a healthcare leader.